Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
Background: Patients with severe alopecia areata (AA), including alopecia totalis (AT) and alopecia universalis (AU), are usually resistant to treatment. While tofacitinib is emerging as a promising therapy for severe AA, little is known about its efficacy and safety in Asians. Objectives: To evalua...
Saved in:
Main Authors: | Ying-Xiu Dai (Author), Chen-Pu Yeh (Author), Chih-Chiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
by: Siddhi B. Chikhalkar, et al.
Published: (2024) -
Short-term efficacy and safety of tofacitinib in the treatment of alopecia areata
by: Zuyan WANG, et al.
Published: (2024) -
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016) -
Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
by: Teresa Rodenas-Herranz, et al.
Published: (2023) -
Acne exacerbation after tofacitinib treatment for alopecia areata
by: Sawsan Alharthi, et al.
Published: (2021)